KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Well (AMWL) Cash & Equivalents (2018 - 2026)

American Well has reported Cash & Equivalents over the past 8 years, most recently at $182.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 20.14% year-over-year to $182.3 million; the TTM value through Dec 2025 reached $182.3 million, down 20.14%, while the annual FY2025 figure was $182.3 million, 20.14% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $182.3 million at American Well, down from $200.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $975.2 million in Q2 2021 and troughed at $112.9 million in Q1 2023.
  • A 5-year average of $378.1 million and a median of $267.0 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 623.86% in 2021 and later plummeted 80.26% in 2022.
  • Year by year, Cash & Equivalents stood at $746.4 million in 2021, then dropped by 27.85% to $538.5 million in 2022, then plummeted by 30.92% to $372.0 million in 2023, then plummeted by 38.63% to $228.3 million in 2024, then fell by 20.14% to $182.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for AMWL at $182.3 million in Q4 2025, $200.9 million in Q3 2025, and $219.1 million in Q2 2025.